Tagged with Sanofi,

Algeria Haissam Chraiteh, country chair for Sanofi Algeria, expands on Sanofi’s ground-breaking foothold in Algerian local production, and how its partnership with the authorities ultimately manifests itself in better provision for patients.   What are your impressions of the Algerian market after two years here as country chair for Sanofi Algeria?…

Algeria The Top 20 Pharma Companies in Algeria based on sales in 2017. Sanofi is way out in front with USD 458.6 million in sales, followed by local champion El Kendi with USD 254.1 million and Danish diabetes specialist Novo Nordisk with USD 239.1 million.

Brexit Brexit, Brexit, Brexit. It’s all anyone can talk about and yet nobody can tell you with certainty what to expect. As the UK’s impending withdrawal from the European Union looms ever closer, industry professionals fervently speculate on how it will affect the country’s position as one of the world’s great…

Portugal Francisco del Val, recently nominated general manager of the business unit Sanofi Genzyme and country head of Sanofi Portugal, has two decades’ experience in the pharma industry. In his first interview in Portugal, Francisco shares with us his priorities and his vision, highlighting the importance of diversification, and innovation through…

Ecuador The top 20 pharma companies in Ecuador in 2017, ranked by value, for both the retail and public markets. Argentinian firm Roemmers leads the way in the retail market, followed by global players Bayer and Sanofi. In terms of Ecuador’s public market, the top three companies are global giants Roche,…

UK Hugo Fry, managing director of Sanofi UK, details the impact of the company’s changing structure, the continued relevance of the UK market despite the challenges around Brexit, and the significance of vaccine R&D and production in the UK.   We have a broad portfolio, from the very first vaccine that…

India Jean-Pierre Baylet, country head for India and cluster head for South Asia at Sanofi Pasteur, provides insights into the progress and room for improvement that lie ahead for India’s immunization program, while highlighting Sanofi’s unrivalled commitment to protecting the Indian population from vaccine- preventable diseases like polio and flu as…

Latvia The top 20 companies in the Latvian pharmaceutical market for 2017, sorted by total value and market share, with data on year-on-year growth. American giant AbbVie ranks first, with an almost six percent market share and astounding 65 percent year-on-year growth, followed by TEVA and Sanofi.

Brazil When combining the sheer size of Brazil – the fifth largest country in the world – with its tropical climate, its largely perfectible infrastructure, and the soaring importance of temperature sensitive biologicals, one understands the urgent need to develop solutions guaranteeing appropriate transport conditions in Brazil. “We may be vaguely…

Poland Agnieszka Grzybowska-Zalewska, general manager of Sanofi Genzyme Poland, reflects on the company’s stable growth over the last few years and the market access challenges they have encountered along the way. Moreover, she highlights the importance of achieving reimbursement for three key products for Multiple Sclerosis and Oncology as well as…

Brazil Pius Hornstein, MSc, PhD, country chair Sanofi Brazil and general manager Pharma, shares his positive outlook on the Brazilian pharma market over the next few years and details Sanofi’s strategy in Brazil; a ‘must-win’ market for the company. Unsatisfied with being just the top-ranked multinational pharma company in Brazil, he…

Tunisia Chokri Jeribi, country chair of Sanofi Tunisia since 2016, is responsible for the development and market leadership hold of Sanofi’s affiliate in Tunisia. In this interview he stresses the importance that clinical trials activities for both the company and the country. Additionally, Jeribi documents the unique collaboration system with local…